John Cox Insider Trading $BIVV Bioverativ Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Cox.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Cox. John Cox is Director in REPLIGEN CORP ($RGEN) and EVP Pharmaceutical Oper & Tech in BIOGEN INC. ($IDPH) and Chief Executive Officer in Bioverativ Inc. ($BIVV) and in Sigilon Therapeutics, Inc. ($SGTX) and Director in Sigilon Therapeutics, Inc. ($SGTX).
John Cox in Bioverativ Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John Cox: Chief Executive Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 08 2018
$BIVV Market Capitalization: $4637.62B
$BIVV Previous Close: $44.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John Cox in Bioverativ Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDPH, BIVV, RGEN, SGTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | D | 44.51 | 193,683 | 8,620,830 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | D | 44.51 | 387,366 | 17,241,661 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | D | 7.82 | 48,230 | 377,159 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | D | 0.00 | 48,678 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | D | 0.00 | 136,364 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Sell | D | 0.00 | 185,094 | 0 | 0 | 185.1 K to 0 (-100.00 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 104.74 | 5,794 | 606,864 | 185,094 | 190.9 K to 185.1 K (-3.04 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 104.30 | 13,973 | 1,457,384 | 190,888 | 204.9 K to 190.9 K (-6.82 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | M | 0.00 | 24,339 | 0 | 48,678 | |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 103.52 | 10,819 | 1,119,983 | 204,861 | 215.7 K to 204.9 K (-5.02 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Buy | M | 0.00 | 24,339 | 0 | 215,680 | 191.3 K to 215.7 K (+12.72 %) |
| Feb 13 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | M | 9.53 | 18,381 | 175,171 | 0 | |
| Feb 13 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 103.05 | 7,672 | 790,600 | 191,341 | 199 K to 191.3 K (-3.86 %) |
| Feb 13 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Buy | M | 9.53 | 18,381 | 175,171 | 199,013 | 180.6 K to 199 K (+10.18 %) |
| Apr 03 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 54.46 | 8,416 | 458,335 | 180,632 | 189 K to 180.6 K (-4.45 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | A | 9.53 | 18,381 | 175,171 | 18,381 | |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | A | 7.82 | 48,230 | 377,159 | 48,230 | |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 43.42 | 6,726 | 292,043 | 189,048 | 195.8 K to 189 K (-3.44 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 47.76 | 6,436 | 307,383 | 195,774 | 202.2 K to 195.8 K (-3.18 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 49.56 | 2,641 | 130,888 | 202,210 | 204.9 K to 202.2 K (-1.29 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 43.42 | 6,986 | 303,332 | 204,851 | 211.8 K to 204.9 K (-3.30 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 47.76 | 8,355 | 399,035 | 211,837 | 220.2 K to 211.8 K (-3.79 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 49.56 | 3,383 | 167,661 | 220,192 | 223.6 K to 220.2 K (-1.51 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 43.42 | 3,404 | 147,802 | 223,575 | 227 K to 223.6 K (-1.50 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Grant | A | 0.00 | 211,679 | 0 | 226,979 | 15.3 K to 227 K (+1,383.52 %) |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | A | 44.51 | 386,675 | 17,210,904 | 386,675 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | A | 44.51 | 193,337 | 8,605,430 | 193,337 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | A | 0.00 | 73,017 | 0 | 73,017 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | A | 44.51 | 386,675 | 17,210,904 | 386,675 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | A | 44.51 | 193,337 | 8,605,430 | 193,337 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | A | 0.00 | 73,017 | 0 | 73,017 |
Page: 1